Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accomplish, Affymetrix, Agilent, agnostic, amplification, art, aspect, AstraZeneca, augmented, back, Baldwin, blue, bodily, certainty, circumvention, classification, COLD, competitor, correctly, correlate, dedicated, defense, dialog, digital, displayed, distraction, divested, domain, double, dramatically, droplet, earliest, easily, easy, elapse, error, exceeding, fall, fastest, fax, feasible, fluid, fold, forefront, frequency, friendly, fruit, Gen, GlaxoSmithKline, greatly, highest, Horizon, IDT, Ineffective, influential, infrastructure, Iona, jeopardized, John, lapse, learn, legacy, Leigh, Leon, longevity, Luther, maker, MDx, Melbourne, mentioned, menu, Michael, middle, monetization, multiplexed, Multiplexing, NGS, Notably, Obama, ordinary, overriding, painful, partnership, plc, precision, premier, prevalence, printing, promised, proof, publishing, Raptor, readily, reality, reconciliation, recruited, redeploying, regimen, remediate, remediated, remote, resigned, scrutiny, secret, shed, showing, sky, slight, spite, spur, sputum, Squibb, stage, statute, step, strategist, stratification, sublicensed, suppressing, sustain, Thermo, Thompson, tier, unbilled, understood, underutilized, underway, Underwriter, undetected, uniform, unlimited, unsecured, uplisting, urine, user, visibility, Waring
Removed:
acted, addressing, aid, antibody, assist, assure, award, binomial, body, calculation, call, cap, cardiovascular, cell, clopidogrel, closure, combined, compel, consolidate, Craig, cultivate, decision, deficit, demonstrated, distributor, DNASEP, Doit, driven, effort, Ernst, exploitation, face, FC, field, force, formula, function, Gaithersburg, Gamma, gene, hold, interpolation, involving, joining, Koppler, lab, lack, larger, lieu, linear, LLP, marketability, Maryland, matched, melanoma, monoclonal, mtDNA, NE, NuclearMitome, OLIGOSEP, operational, OPTIMASE, OPTIMIZED, panel, participated, pathway, Patzig, pharmacological, plasma, Plavix, promotion, recapitalization, receiving, receptor, regionally, revaluation, RNASEP, Robert, Scan, secured, selection, serum, shift, shortage, sought, stop, Stratagene, strike, strong, susceptibility, Tuttle, WAVEMAKER, workforce, Young
Filing tables
Filing exhibits
Related press release
PRPO similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statements (No.’s 333-41714, 333-69334, 333-139999, and 333-196712) on Form S-8 and Registration Statements (No.’s 333-200313 and 333-201907) on Form S-3 of Transgenomic, Inc. and Subsidiary of our report dated March 14, 2013, relating to our audit of the consolidated statements of operations, comprehensive loss, stockholders' equity, and cash flows of Transgenomic, Inc. and Subsidiary for the year ended December 31, 2012, included in this Annual Report on Form 10-K for the year ended December 31, 2014.
/s/ McGladrey LLP
Omaha, Nebraska
April 15, 2015